Stellest Myopia Control

Introducing Stellest® Lenses for Myopia Control

We are excited to offer Essilor Stellest® lenses, the first FDA-authorized spectacle lens designed specifically to slow the progression of myopia in children ages 6–12 while also correcting their refractive error. The U.S. Food and Drug Administration granted marketing authorization in September 2025 based on clinical evidence demonstrating both safety and effectiveness for pediatric myopia management.

What Makes Stellest Lenses Special?

Instead of just correcting vision, Stellest lenses use an innovative optical design with peripheral lenslets—tiny, raised elements arranged around a clear central zone—that help create controlled peripheral defocus. This design is believed to signal the eye to slow axial growth, which is the primary structural change that drives worsening myopia

Proven Benefits for Growing Eyes

Clinical studies reviewed by the FDA show that Stellest lenses can:

• Slow myopia progression by an average of 71% compared to standard single-vision glasses

• Reduce excessive eye growth by 53%, which may lower the risk of future eye health complications

• Provide a safe, non-invasive option ideal for children ages 6–12, especially for those not ready for contact lenses

Why Myopia Control Matters

As myopia increases, so does the lifetime risk of serious eye conditions such as retinal detachment, glaucoma, and myopic macular degeneration. Starting myopia control early can help protect your child’s long-term eye health and vision.

Is Stellest Right for Your Child?

Our doctors will evaluate your child’s prescription, eye growth, and lifestyle to determine whether Stellest lenses are an appropriate option as part of a personalized myopia management plan.

Contact our office today to schedule a myopia control consultation and learn how Stellest lenses may help slow your child’s nearsightedness and protect their vision for the future.

Book Your Consultation Today